Not applicableEnded earlyNCT01211639
What this trial is testing
Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Who this might be right for
Progressive Multifocal Leukoencephalopathy
Biogen 24
Showing 20 of 32 results